Drug & intervention
insulin degludec
RxCUI 1670007
RxNorm ingredient and formulation relationships
Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.
Loading RxNorm relationships…
Clinical trials
40 shownA Study Comparing SHR-3167 and Insulin Degludec in Type 2 Diabetic Subjects Treated With Basal Insulin With or Without Oral Antidiabetic DrugsNCT07018453 · 2025-07-16
ACTIVE_NOT_RECRUITINGA Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal InsulinNCT06767748 · 2025-02-15
ACTIVE_NOT_RECRUITINGA Research Study of a New Medicine NNC0363-1063 in Healthy Participants and Participants With Type 1 DiabetesNCT06685185 · 2024-11-12
COMPLETEDA Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)NCT06280703 · 2024-05-15
COMPLETEDA Study to Test How a New Long-acting Insulin Works in the Body of Patients With Type 2 Diabetes During Exercise and Prolonged FastingNCT06288412 · 2024-02-26
COMPLETEDA Research Study in Saudi Arabia to Understand How the Dose Check App Used With Tresiba Treatment Helps to Control Blood Sugar LevelNCT06153537 · 2023-11-29
COMPLETEDA Study to Investigate the Safety and Tolerability of LY3938577 in Healthy Participants and Participants With Type 2 Diabetes MellitusNCT06132126 · 2023-11-17
COMPLETEDA Trial Comparing the Efficacy and Safety of GZR4 Injection Versus Insulin Degludec in Subjects with Type 2 Diabetes MellitusNCT06202079 · 2023-08-11
COMPLETEDA Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GZR4 in Subjects With Type 2 DiabetesNCT06553248 · 2023-03-22
COMPLETEDA Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection TherapyNCT05463744 · 2022-08-12
COMPLETEDA Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First TimeNCT05362058 · 2022-06-03
COMPLETEDA Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal InsulinNCT05275400 · 2022-03-08
COMPLETEDEvaluation of Glycemic Control in Adults With Type 1 Diabetes When Switching to Insulin DegludecNCT05434559 · 2022-02-20
COMPLETEDBasal Plus GLP1-ra on Glycemic Variability in CKDNCT05218915 · 2022-01-28
COMPLETEDA Research Study Looking at How the Use of NovoPen® 6 for Treatment With Tresiba® & Fiasp® Affects the Blood Sugar Level in Patients With Type 1 Diabetes as Part of Local Clinical PracticeNCT05069545 · 2021-10-11
COMPLETEDA Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6)NCT04848480 · 2021-04-30
COMPLETEDA Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)NCT04795531 · 2021-03-24
COMPLETEDA Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Use Daily InsulinNCT04770532 · 2021-03-05
COMPLETEDA Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin BeforeNCT04760626 · 2021-03-01
COMPLETEDA Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral AntidiabeticsNCT04663282 · 2021-02-04
COMPLETEDTransition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2DNCT04538352 · 2021-01-18
COMPLETEDA Study of LY900014 and Insulin Degludec in Participants With Type 1 DiabetesNCT04585776 · 2020-10-30
COMPLETEDResearch Study to Compare a New Medicine "Fast-acting Insulin Aspart" to Another Medicine "Insulin Aspart" in Chinese People With DiabetesNCT04588259 · 2020-10-09
COMPLETEDA Study to Look at the Safety of NNC0363-0845 in Healthy People and People With Type 1 DiabetesNCT04569994 · 2020-09-30
COMPLETEDA Study of LY3209590 in Participants With Type 1 DiabetesNCT04450407 · 2020-07-06
COMPLETEDA Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes MellitusNCT04450394 · 2020-07-01
COMPLETEDA Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in RussiaNCT04315688 · 2020-03-30
COMPLETEDA Study of LY3209590 in Japanese Participants With Type 2 Diabetes MellitusNCT04276428 · 2020-02-28
COMPLETEDComparison of Glargine to Degludec Insulin Transition With or Without a Bridging Glargine DoseNCT04623086 · 2020-02-14
COMPLETEDA Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 DiabetesNCT03952130 · 2019-05-29
COMPLETEDA Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 DiabetesNCT03952143 · 2019-05-27
COMPLETEDRemission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegLiraNCT03862716 · 2019-04-23
COMPLETEDA Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 DiabetesNCT03740919 · 2019-04-07
COMPLETEDA Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 DiabetesNCT03882970 · 2019-04-01
COMPLETEDA Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in Saudi ArabiaNCT03785522 · 2018-12-23
COMPLETEDComparison of Insulin Degludec With Insulin Glargine U100 for Adults With Type 1 Diabetes Crossing Multiple Time Zones.NCT03668808 · 2018-11-16
COMPLETEDA Study of LY3209590 in Participants With Type 2 Diabetes MellitusNCT03736785 · 2018-11-15
COMPLETEDA Canadian Study of the Effectiveness of Tresiba® (Insulin Degludec) After Switching Basal Insulin in a Population With Type 1 or Type 2 Diabetes MellitusNCT03674866 · 2018-10-29
COMPLETEDA Research Study to Compare the Effect of Insulin Degludec and Insulin Glargine on Blood Sugar Levels in People With Type 2 Diabetes - the SWITCH PRO StudyNCT03687827 · 2018-10-02
COMPLETEDFlexible Insulin Therapy Untethered Insulin Regimen in Avidly Exercising Patients With Type 1 Diabetes: FIT UntetheredNCT03838783 · 2018-05-15
UNKNOWNConditions being studied
Research locations
DallasTexas, United States38FresnoCalifornia, United States25RockvilleMaryland, United States25San AntonioTexas, United States24ChattanoogaTennessee, United States23HoustonTexas, United States23ChicagoIllinois, United States22Las VegasNevada, United States22MiamiFlorida, United States22AustinTexas, United States21JacksonvilleFlorida, United States20PhiladelphiaPennsylvania, United States20
Leading sponsors
Novo Nordisk A/S96Eli Lilly and Company16Gan and Lee Pharmaceuticals, USA2Jiangsu HengRui Medicine Co., Ltd.2Sanofi2Elaine Chow1Gan & Lee Pharmaceuticals.1Insel Gruppe AG, University Hospital Bern1LMC Diabetes & Endocrinology Ltd.1Population Health Research Institute1prof dr Pieter Gillard1Sansum Diabetes Research Institute1The Cleveland Clinic1University of Guadalajara1University of Padova1
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.